Alpha 2.0
Login Register
» Authors » Kerstin Heurling

Kerstin Heurling

Explore the profile of Kerstin Heurling including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 600
Followers 0
Related Specialties
Neurology
Endocrinology
Radiology
Top 10 Co-Authors
Mark Lubberink
Antoine Leuzy
Michael Scholl
Christopher Buckley
Aruna Chakrabarty
Gill Farrar
Thomas G Beach
Azzam Ismail
Adrian P L Smith
Michelle Zanette
Published In
Acta Neuropathol Commun
Ann Nucl Med
Horm Metab Res
Am J Nucl Med Mol Imaging
J Cereb Blood Flow Metab
Affiliations
Soon will be listed here.
Recent Articles
1.
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study
Latva-Rasku A, Rebelos E, Tuisku J, Aarnio R, Bhowmik A, Keskinen H, et al.
Diabetes Care . 2024 Jun; 47(9):1630-1637. PMID: 38941156
Objective: The aim of this study was to investigate the impact of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin on tissue fatty acid (FA) uptake in the skeletal muscle, brain,...
2.
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study
Oldgren J, Laurila S, Akerblom A, Latva-Rasku A, Rebelos E, Isackson H, et al.
Diabetes Obes Metab . 2021 Feb; 23(7):1505-1517. PMID: 33625777
Aim: To explore the early effects of dapagliflozin on myocardial function and metabolism in patients with type 2 diabetes without heart failure. Materials And Methods: Patients with type 2 diabetes...
3.
Pre- and postoperative Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours
Tjornstrand A, Casar-Borota O, Heurling K, Scholl M, Gjertsson P, Ragnarsson O, et al.
Clin Endocrinol (Oxf) . 2021 Jan; 94(6):956-967. PMID: 33484167
Objectives: Somatostatin receptors (SSTRs) are potential targets for detecting pituitary neuroendocrine tumours (PitNETs) that can be visualized effectively with Ga-labelled PET tracers. With this study, we have evaluated the diagnostic...
4.
Pharmacokinetic modelling for the simultaneous assessment of perfusion and F-flutemetamol uptake in cerebral amyloid angiopathy using a reduced PET-MR acquisition time: Proof of concept
Papanastasiou G, Rodrigues M, Wang C, Heurling K, Lucatelli C, Salman R, et al.
Neuroimage . 2020 Nov; 225:117482. PMID: 33157265
Purpose: Cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease associated with perivascular β-amyloid deposition. CAA is also associated with strokes due to lobar intracerebral haemorrhage (ICH). F-flutemetamol amyloid...
5.
Validation of a spatial normalization method using a principal component derived adaptive template for [F]florbetaben PET
Leuzy A, Heurling K, De Santi S, Bullich S, Hansson O, Lilja J
Am J Nucl Med Mol Imaging . 2020 Sep; 10(4):161-167. PMID: 32929394
Quantification may help in the context of amyloid-β positron emission tomography (PET). Quantification typically requires that PET images be spatially normalized, a process that can be subject to bias. We...
6.
Correction to: Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
Thal D, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, et al.
Acta Neuropathol Commun . 2020 Aug; 8(1):121. PMID: 32746942
An amendment to this paper has been published and can be accessed via the original article.
7.
Disturbances in brain energy metabolism in insulin resistance and diabetes and Alzheimer's disease - Learnings from brain imaging biomarkers
Heurling K, Johansson E, Leuzy A
Int Rev Neurobiol . 2020 Aug; 154:111-130. PMID: 32739001
Medical imaging techniques, such as structural and functional magnetic resonance imaging and positron emission tomography, have been used to gain a better understanding of the alterations of the metabolic processes...
8.
Simulating the effect of cerebral blood flow changes on regional quantification of [F]flutemetamol and [F]florbetaben studies
Heeman F, Yaqub M, Lopes Alves I, Heurling K, Bullich S, Gispert J, et al.
J Cereb Blood Flow Metab . 2020 Apr; 41(3):579-589. PMID: 32281514
Global and regional changes in cerebral blood flow (CBF) can result in biased quantitative estimates of amyloid load by PET imaging. Therefore, the current simulation study assessed effects of these...
9.
Lower Ga-DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland-A proof-of-concept study
Tjornstrand A, Casar-Borota O, Heurling K, Scholl M, Gjertsson P, Himmelman J, et al.
Clin Endocrinol (Oxf) . 2019 Dec; 92(3):222-231. PMID: 31868239
Objectives: Ga-DOTATOC PET targets somatostatin receptors (SSTRs) and is well established for the detection of SSTR-expressing tumors, such as gastrointestinal neuroendocrine tumors. Pituitary adenomas, recently designated as pituitary neuroendocrine tumors...
10.
Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
Thal D, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, et al.
Acta Neuropathol Commun . 2019 Nov; 7(1):178. PMID: 31727169
Alzheimer's disease (AD)-related amyloid β-peptide (Aβ) pathology in the form of amyloid plaques and cerebral amyloid angiopathy (CAA) spreads in its topographical distribution, increases in quantity, and undergoes qualitative changes...